Concepedia

Jeffrey A. Kester

JA

5

Publications

226

Citations

5

H-Index

1992

Active since

Affiliations

Abbott Fund(Current)

Jeffrey A. Kester is an author at Abbott Fund specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1992–1996

5

Publications

5

2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET<sub>A</sub> Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722

Martin Winn, Thomas W von Geldern, Terry J. Opgenorth et al. · Journal of Medicinal Chemistry · 1996 · 110 citations · Full text

, , +12

Azole Endothelin Antagonists. 2. Structure−Activity Studies

Thomas W von Geldern, Jeffrey A. Kester, Radhika Bal et al. · Journal of Medicinal Chemistry · 1996 · 44 citations · Full text

, , +14

Azole Endothelin Antagonists. 3. Using Δ log <i>P</i> as a Tool To Improve Absorption

Thomas W von Geldern, Daniël J. Hoffman, Jeffrey A. Kester et al. · Journal of Medicinal Chemistry · 1996 · 35 citations · Full text

Azole Endothelin Antagonists. 1. A Receptor Model Explains an Unusual Structure−Activity Profile

Thomas W von Geldern, Charles W. Hutchins, Jeffrey A. Kester et al. · Journal of Medicinal Chemistry · 1996 · 25 citations · Full text

Cholinergic Agents: Effect of Methyl Substitution in a Series of Arecoline Derivatives on Binding to Muscarinic Acetylcholine Receptors

Walter H. Moos, Stephen C. Bergmeier, Linda L. Coughenour et al. · Journal of Pharmaceutical Sciences · 1992 · 12 citations

, , +11

Rows per page

1–5 of 5